EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSIPUG00000009656
Gene Symbol: MAP3K5
2 Cross references
203 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 8

Ensembl ID : ENSIPUG00000011487
Gene Symbol: MAP3K8
3 Cross references
200 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSIPUG00000007050
Gene Symbol: MGLL
3 Cross references
208 Possible Orthologues:

Myb-Like Protein Q

Ensembl ID : ENSIPUG00000010485
Gene Symbol: SI:CH211-79M20.1
3 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSIPUG00000016873
Gene Symbol: NPR1A
3 Cross references
193 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSIPUG00000016507
Gene Symbol: NPR2
3 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSIPUG00000004382
Gene Symbol: NPR2
4 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSIPUG00000008136
Gene Symbol: NPR3
3 Cross references
212 Possible Orthologues:

Neprilysin

Ensembl ID : ENSIPUG00000010912
Gene Symbol: LOC108264737
3 Cross references
234 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSIPUG00000012666
Gene Symbol: LOC108274439
3 Cross references
183 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSIPUG00000017974
Gene Symbol: NPY2R
3 Cross references
184 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSIPUG00000010753
Gene Symbol: NTSR1
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).